TASCOM Co.,Ltd. (XKON:336040)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,800.00
-100.00 (-2.56%)
At close: Jan 30, 2026
-9.52%
Market Cap21.71B +25.6%
Revenue (ttm)5.53B +85.0%
Net Income-1.74B
EPS-824.00
Shares Out5.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume36
Average Volume264
Open4,000.00
Previous Close3,900.00
Day's Range3,500.00 - 4,000.00
52-Week Range2,400.00 - 5,280.00
Beta0.19
RSI60.09
Earnings Daten/a

About TASCOM

TASCOM Co.,Ltd. manufactures and distributes diabetic supplies in South Korea. Its products include blood glucose measurement system-acuraview, BD ultra fine PRO pen needle, syringes-BD ultrafine syringes, Ido sharp container, and Ido safety lancet. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021. TASCOM Co.,Ltd. was founded in 2014 and is headquartered in Anyang-Si, South Korea. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 336040
Full Company Profile

Financial Performance

In 2018, TASCOM's revenue was 5.53 billion, an increase of 84.97% compared to the previous year's 2.99 billion. Losses were -1.74 billion, 35.2% more than in 2017.

Financial Statements